224 related articles for article (PubMed ID: 25482303)
1. Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway.
Alshaker H; Krell J; Frampton AE; Waxman J; Blyuss O; Zaikin A; Winkler M; Stebbing J; Yagüe E; Pchejetski D
Breast Cancer Res; 2014 Oct; 16(5):426. PubMed ID: 25482303
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer.
Alshaker H; Wang Q; Frampton AE; Krell J; Waxman J; Winkler M; Stebbing J; Cooper C; Yagüe E; Pchejetski D
Breast Cancer Res Treat; 2015 Jan; 149(1):59-67. PubMed ID: 25481644
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cells.
Long JS; Edwards J; Watson C; Tovey S; Mair KM; Schiff R; Natarajan V; Pyne NJ; Pyne S
Mol Cell Biol; 2010 Aug; 30(15):3827-41. PubMed ID: 20516217
[TBL] [Abstract][Full Text] [Related]
4. Leptin stimulates both JAK2-dependent and JAK2-independent signaling pathways.
Jiang L; Li Z; Rui L
J Biol Chem; 2008 Oct; 283(42):28066-73. PubMed ID: 18718905
[TBL] [Abstract][Full Text] [Related]
5. High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients.
Watson C; Long JS; Orange C; Tannahill CL; Mallon E; McGlynn LM; Pyne S; Pyne NJ; Edwards J
Am J Pathol; 2010 Nov; 177(5):2205-15. PubMed ID: 20889557
[TBL] [Abstract][Full Text] [Related]
6. Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer.
Ohotski J; Long JS; Orange C; Elsberger B; Mallon E; Doughty J; Pyne S; Pyne NJ; Edwards J
Br J Cancer; 2012 Apr; 106(8):1453-9. PubMed ID: 22460268
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting.
Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G
Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173
[TBL] [Abstract][Full Text] [Related]
8. SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells.
Piazza TM; Lu JC; Carver KC; Schuler LA
Mol Endocrinol; 2009 Feb; 23(2):202-12. PubMed ID: 19056863
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine kinase 2 prevents the nuclear translocation of sphingosine 1-phosphate receptor-2 and tyrosine 416 phosphorylated c-Src and increases estrogen receptor negative MDA-MB-231 breast cancer cell growth: The role of sphingosine 1-phosphate receptor-4.
Ohotski J; Rosen H; Bittman R; Pyne S; Pyne NJ
Cell Signal; 2014 May; 26(5):1040-7. PubMed ID: 24486401
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation.
Pinho FG; Frampton AE; Nunes J; Krell J; Alshaker H; Jacob J; Pellegrino L; Roca-Alonso L; de Giorgio A; Harding V; Waxman J; Stebbing J; Pchejetski D; Castellano L
Cancer Res; 2013 Oct; 73(19):5936-48. PubMed ID: 23928990
[TBL] [Abstract][Full Text] [Related]
11. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
12. Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways.
Strong AL; Strong TA; Rhodes LV; Semon JA; Zhang X; Shi Z; Zhang S; Gimble JM; Burow ME; Bunnell BA
Breast Cancer Res; 2013; 15(5):R102. PubMed ID: 24176089
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
Nagahashi M; Ramachandran S; Kim EY; Allegood JC; Rashid OM; Yamada A; Zhao R; Milstien S; Zhou H; Spiegel S; Takabe K
Cancer Res; 2012 Feb; 72(3):726-35. PubMed ID: 22298596
[TBL] [Abstract][Full Text] [Related]
14. Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells.
Wang L; Tang C; Cao H; Li K; Pang X; Zhong L; Dang W; Tang H; Huang Y; Wei L; Su M; Chen T
Cancer Biol Ther; 2015; 16(8):1220-30. PubMed ID: 26121010
[TBL] [Abstract][Full Text] [Related]
15. Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding.
Sen B; Saigal B; Parikh N; Gallick G; Johnson FM
Cancer Res; 2009 Mar; 69(5):1958-65. PubMed ID: 19223541
[TBL] [Abstract][Full Text] [Related]
16. Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1.
Lim KT; Cosgrave N; Hill AD; Young LS
Breast Cancer Res; 2006; 8(3):R33. PubMed ID: 16805920
[TBL] [Abstract][Full Text] [Related]
17. Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1.
Alshaker H; Wang Q; Böhler T; Mills R; Winkler M; Arafat T; Kawano Y; Pchejetski D
Sci Rep; 2017 Jun; 7(1):3493. PubMed ID: 28615679
[TBL] [Abstract][Full Text] [Related]
18. Leptin--a growth factor in normal and malignant breast cells and for normal mammary gland development.
Hu X; Juneja SC; Maihle NJ; Cleary MP
J Natl Cancer Inst; 2002 Nov; 94(22):1704-11. PubMed ID: 12441326
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer.
Ohotski J; Edwards J; Elsberger B; Watson C; Orange C; Mallon E; Pyne S; Pyne NJ
Int J Cancer; 2013 Feb; 132(3):605-16. PubMed ID: 22733311
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin.
Yin N; Wang D; Zhang H; Yi X; Sun X; Shi B; Wu H; Wu G; Wang X; Shang Y
Cancer Res; 2004 Aug; 64(16):5870-5. PubMed ID: 15313931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
